3-D mammography clears FDA

April 11, 2001

Tuned-aperture CT (TACT) has passed FDA review. The 3-D mammography system promises to better visualize tumors in dense parts of the breast or other regions often obscured by overlying tissues. The technology, which was licensed by Wake Forest University

Tuned-aperture CT (TACT) has passed FDA review. The 3-D mammography system promises to better visualize tumors in dense parts of the breast or other regions often obscured by overlying tissues. The technology, which was licensed by Wake Forest University School of Medicine to Instrumentarium Imaging, is an integral part of the Delta 32 TACT 3-D breast imaging system, which will be available exclusively on Instrumentarium Imaging’s Diamond Breast Care System. Using TACT, Instrumentarium has also developed a dental imaging system and a computer program called CliniView.